Core Scientific, Inc.
CORZ · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 1.6% | -21.5% | 17.6% | – |
| Cost of Goods Sold | $0 | $0 | $1 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 23.7% | 24.6% | 1.3% | 43.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $2 | $0 |
| Operating Expenses | $0 | $0 | $2 | $0 |
| Operating Income | -$0 | $0 | -$2 | $0 |
| % Margin | -3.8% | 1.8% | -329.5% | 30.6% |
| Other Income/Exp. Net | -$1 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$1 | -$0 | -$2 | $0 |
| Tax Expense | $0 | $0 | -$0 | $0 |
| Net Income | -$1 | -$0 | -$2 | $0 |
| % Margin | -257.5% | -49.1% | -335.2% | 8.7% |
| EPS | -5.14 | -0.65 | -6.3 | 0.23 |
| % Growth | -690.8% | 89.7% | -2,839.1% | – |
| EPS Diluted | -5.14 | -0.65 | -6.3 | 0.2 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$0 | -$2 | $0 |
| % Margin | -226.6% | -12.6% | -287.4% | 25.9% |